Atypical Presentation of Liver Metastases of Prostate Cancer in 68Ga-PSMA-11 PET/CT

被引：0

作者：

Stanzel, Susanne ^{[1
,2
]}

Weitzer, Friedrich ^{[1
]}

Janek, Elmar

Plhak, Elisabeth ^{[1
]}

Aigner, Reingard M. ^{[1
]}

机构：

[1] Med Univ Graz, Dept Radiol, Graz, Austria

[2] Med Univ Graz, De Dept Radiol, Div Nucl Med, Auenbruggerpl 9A, A-8036 Graz, Austria

来源：

CLINICAL NUCLEAR MEDICINE | 2023年 / 48卷 / 12期

关键词：

Ga-68-PSMA-11; PET/CT; metastatic castration-resistant prostate cancer; PSMA-negative liver metastases;

D O I：

10.1097/RLU.0000000000004898

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

Ga-68-PSMA-11 (Ga-68-prostate-specific membrane antigen-11) PET/CT continues to have a great clinical value for staging in prostate cancer. Lymph nodes and bone are the most typical metastatic sites of prostate cancer, whereas liver metastases are rare and usually show focally increased tracer uptake in Ga-68-PSMA-11 PET/CT. Here, we present an 88-year-old man with histologically proven metastatic castration-resistant prostate cancer and extensive PSMA-negative liver metastases identified by(68)Ga-PSMA-11 PET/CT. This finding is remarkable because the decreased liver uptake of Ga-68-PSMA-11 may resemble a primary hepatic tumor.

引用

页码：1064 / 1065

页数：2

共 50 条

[21] 68Ga-PSMA-11 PET/CT for prostate cancer staging and risk stratification in Chinese patients
Zang, Shiming
Shao, Guoqiang
Cui, Can
Li, Tian-Nv
Huang, Yue
Yao, Xiaochen
Fan, Qiu
Chen, Zejun
Du, Jin
Jia, Ruipeng
Sun, Hongbin
Hua, Zichun
Tang, Jun
Wang, Feng
ONCOTARGET, 2017, 8 (07) : 12247 - 12258
[22] 68Ga-PSMA-11 PET/CT: the rising star of nuclear medicine in prostate cancer imaging?
Christian Uprimny
Wiener Medizinische Wochenschrift, 2019, 169 : 3 - 11
[23] Impact of 68Ga-PSMA-11 PET/CT on the Management of Prostate Cancer Patients with Biochemical Recurrence
Calais, Jeremie
Fendler, Wolfgang P.
Eiber, Matthias
Gartmann, Jeannine
Chu, Fang-I
Nickols, Nicholas G.
Reiter, Robert E.
Rettig, Matthew B.
Marks, Leonard S.
Ahlering, Thomas E.
Huynh, Linda M.
Slavik, Roger
Gupta, Pawan
Quon, Andrew
Allen-Auerbach, Martin S.
Czernin, Johannes
Herrmann, Ken
JOURNAL OF NUCLEAR MEDICINE, 2018, 59 (03) : 434 - 441
[24] Staging Prostate Cancer with 68Ga-PSMA-11 PET/CT in the Elderly: Is Preimaging Biopsy Imperative?
Kesler, Mikhail
Cohen, Dan
Levine, Charles
Sarid, David
Keizman, Daniel
Yossepowitch, Ofer
Even-Sapir, Einat
JOURNAL OF NUCLEAR MEDICINE, 2023, 64 (07) : 1030 - 1035
[25] 68Ga-PSMA-11 PET/CT: the rising star of nuclear medicine in prostate cancer imaging?
Uprimny, Christian
WIENER MEDIZINISCHE WOCHENSCHRIFT, 2019, 169 (1-2) : 3 - 11
[26] PET/CT with 68Ga-PSMA-11 for detection of rib involvement in a subgroup of prostate cancer patients
Calderoni, L.
Farolfi, A.
Mei, R.
Telo, S.
Fanti, S.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S592 - S592
[27] Incidence of intrathoracic (IT) metastases detected by 68Ga-PSMA-11 PET in early stage prostate cancer (PC).
Aggarwal, Rahul Raj
Cooperberg, Matthew R.
Hao Gia Nguyen
Small, Eric Jay
Ryan, CharlesJ.
Feng, Felix Yi-Chung
Chang, Albert
Greene, Kirsten L.
Carroll, Peter
Hope, Tom
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[28] 68Ga-PSMA-PET/CT for the evaluation of liver metastases in patients with prostate cancer
Damjanovic, Jonathan
Janssen, Jan-Carlo
Prasad, Vikas
Diederichs, Gerd
Walter, Thula
Brenner, Winfried
Makowski, Marcus R.
CANCER IMAGING, 2019, 19 (1)
[29] Comparison of 68Ga-PSMA-11 PET/CT and 18F-Fluciclovine PET/CT in recurrent Prostate Cancer
Ceci, F.
Polverari, G.
Gartmann, J.
Fendler, W.
Eiber, M.
Herrmann, K.
Czernin, J.
Calais, J.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S150 - S150
[30] 68Ga-PSMA-PET/CT for the evaluation of liver metastases in patients with prostate cancer
Jonathan Damjanovic
Jan-Carlo Janssen
Vikas Prasad
Gerd Diederichs
Thula Walter
Winfried Brenner
Marcus R. Makowski
Cancer Imaging, 19

← 1 2 3 4 5 →